Alpha Financial Partners’s AbbVie ABBV Stock Holding History

Alpha Financial Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$386K	Sell	1,775 -23	-1%	-$5.1K	0.23%	65
2025 Q4	$411K	Buy	1,798 +7	+0.4%	+$1.59K	0.25%	59
2025 Q3	$415K	Buy	1,791 +172	+11%	+$35K	0.27%	54
2025 Q2	$301K	Sell	1,619 -37	-2%	-$6.88K	0.22%	65
2025 Q1	$347K	Buy	1,656 +126	+8%	+$24.5K	0.28%	50
2024 Q4	$272K	Buy	+1,530	New	+$281K	0.22%	57
2024 Q3	–	Sell	-1,808	Closed	-$310K	–	109
2024 Q2	$310K	Buy	1,808 +139	+8%	+$23K	0.27%	44
2024 Q1	$304K	Buy	1,669 +2	+0.1%	+$345	0.28%	43
2023 Q4	$258K	Sell	1,667 -797	-32%	-$116K	0.25%	54
2023 Q3	$367K	Buy	2,464 +2	+0.1%	+$294	0.43%	40
2023 Q2	$332K	Buy	2,462 +26	+1%	+$3.81K	0.35%	56
2023 Q1	$388K	Sell	2,436 -33	-1%	-$5.04K	0.44%	42
2022 Q4	$399K	Buy	+2,469	New	+$379K	0.48%	40

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha Financial Partners's ABBV Position: Q1 2026 in Review

Alpha Financial Partners reduced its AbbVie (ABBV) stake by 1.3% in Q1 2026, selling an estimated $5.1K and leaving 1,775 shares worth $386K. The position accounts for 0.23% of the portfolio, ranked #65.

Alpha Financial Partners first reported a position in ABBV in Q4 2022 and has held it in 13 quarters since. The position peaked at $415K in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Alpha Financial Partners held 1,775 shares of AbbVie worth $386K as of Q1 2026.
Alpha Financial Partners sold 23 AbbVie shares in Q1 2026, an estimated $5.1K.
AbbVie made up 0.23% of Alpha Financial Partners's portfolio in Q1 2026, its #65 holding.
Alpha Financial Partners first reported a position in AbbVie in Q4 2022 and has held it in 13 quarters since.
Alpha Financial Partners's AbbVie position peaked at $415K in Q3 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Alpha Financial Partners's 13F filing for Q1 2026, filed 13 May 2026.